Healthcare professionals' perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda.

ABSTRACT:

Background

Efficient testing to identify poor quality artemisinin-based combination therapy (ACT) is important to optimize efforts to control and eliminate malaria. Healthcare professionals interact with both ACT and malaria patients they treat and hence could observe, first-hand, suspect poor quality artemisinin-based combinations linked to poor malaria treatment outcomes and the factors associated with inappropriate use or treatment failure.

Methods

A cross-sectional study of 685 HCP perspectives about the efficacy of ACT between June and July 2018 at selected health facilities in Uganda. Medicine samples were obtained from the seven regions of Uganda and tested for quality using the Germany Pharma Health Fund™ minilabs.

Results

The average age of the 685 respondent

SUBMITTER: Ndagije HB 

PROVIDER: S-EPMC7011371 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature